What Lejam 60mg Treats: Main Uses and Benefits

The primary therapeutic use of Lejam 60mg is applied across domains where additional symptomatic support is needed for clinically diagnosed Premature Ejaculation (PE) in adult men. This medication is considered relevant in conditions characterized by periods of heightened symptoms and physiological stress, encompassing both lifelong PE and acquired PE. The medicine is commonly used to help with the central symptom cluster of rapid ejaculation, where the core issue is a persistent and disruptive lack of control over timing.

---

A primary patient-oriented benefit may be the temporary prolongation of the Intravaginal Ejaculatory Latency Time (IELT), which plays a role in managing symptoms related to heightened physiological activity. This supportive relief is often used during phases when symptoms become more noticeable, assisting with functional stability. Furthermore, by supporting timing, the drug contributes to easing the overall symptom load and helps address the emotional distress that interferes with daily comfort, such as performance anxiety and low self-esteem.

“The therapeutic goal is focused on providing supportive relief that helps patients cope more steadily with symptom fluctuations during episodes of sexual activity.”

---

Quick Fact: Relief for Premature Ejaculation

Domain of Relief	Symptom Cluster Addressed	Primary Benefit
Functional Timing	Reduced ejaculatory control, rapid timing (short IELT)	Supports temporary prolongation of IELT
Emotional Distress	Performance anxiety, low self-esteem, interpersonal difficulty	Contributes to easing the overall symptom load
Clinical Context	Persistent symptoms (lifelong/acquired PE)	Applied for short-term symptomatic assistance

Regulatory References

1. European Medicines Agency (EMA) product information

Official Eligibility for Lejam 60mg

The eligibility for using Lejam 60mg (Dapoxetine) is highly restricted and defined by official regulatory criteria concerning age, medical history, and specific organ function. The medicine is licensed only for adult men aged 18 to 64 years who have a clinical diagnosis of Premature Ejaculation (PE) and meet all defined symptomatic criteria.

---

Populations That Must Not Use Lejam 60mg (Contraindications)

Lejam 60mg is contraindicated and must not be used by patients with:

• Significant Pathological Cardiac Conditions: This includes heart failure (NYHA Class II-IV), specific heart rhythm problems (conduction abnormalities), or significant ischemic heart disease.
• Liver Impairment: Patients with moderate or severe hepatic impairment (Child-Pugh Class B and C).
• Psychiatric History: Individuals with a history of mania or severe depression.
• Syncope: A history of fainting.
• Concomitant Drugs: Use with Monoamine Oxidase Inhibitors (MAOIs), Thioridazine, or potent CYP3A4 inhibitors is forbidden.

---

Restricted and Non-Recommended Use

Use is not recommended in men aged 65 years and over because safety and efficacy are not established in this age group. It is also not recommended for patients with severe renal impairment or individuals under the age of 18.

Pregnancy and Lactation Eligibility Status: The drug is not indicated for use by women.

Interactions with other medicines and products

Lejam 60mg (Dapoxetine) has officially documented interaction patterns that necessitate specific regulatory constraints regarding co-administration with other substances.

Contraindicated Combinations

Co-administration is formally contraindicated with several classes of medicinal products and substances due to the high risk of serious adverse outcomes. This includes Monoamine Oxidase Inhibitors (MAOIs), Thioridazine, and other potent Serotonin Reuptake Inhibitors due to the risk of Serotonin Syndrome. Additionally, potent CYP3A4 Inhibitors (e.g., Ketoconazole, Ritonavir) are contraindicated because they significantly increase Dapoxetine's plasma concentration (exposure).

Timing and Separation Requirements

Mandatory washout periods are required when transitioning between Dapoxetine and certain serotonergic medicines. Individuals must wait 14 days after discontinuing an MAOI or similar serotonergic agent before starting Lejam 60mg. Conversely, a 7-day separation is required after stopping Dapoxetine before starting a serotonergic product.

Other Documented Interactions

Pharmacodynamic interactions exist with agents that affect blood pressure, such as Phosphodiesterase Type 5 (PDE5) Inhibitors, which may increase the risk of orthostatic hypotension. The official profile advises avoiding the use of alcohol due to its potential to enhance alcohol-related neurocognitive effects and increase the risk of syncope. Furthermore, Dapoxetine is contraindicated in individuals with moderate or severe hepatic impairment due to the reduction in metabolic clearance.

How Lejam 60mg Works

The mechanism of Dapoxetine is a targeted intervention within the central nervous system, specifically designed to modulate the speed of neural communication that governs the ejaculatory reflex.

Blocking the Serotonin Transporter (SERT)

The core action involves the active ingredient and its active metabolite acting as selective Serotonin Reuptake Inhibitors (SSRIs). They achieve this by blocking the Serotonin Transporter (SERT) protein on presynaptic nerve terminals, which prevents the rapid clearance of Serotonin (5-HT) from the synaptic cleft. This foundational molecular block rapidly increases the effective concentration and duration of 5-HT signaling, which is essential for initiating the drug’s downstream inhibitory effects.

Enhancement of Spinal Inhibitory Control

The elevated Serotonin levels activate descending inhibitory pathways originating in the brainstem, channeling a heightened inhibitory signal toward the Spinal Ejaculation Generator (SEG). This central action raises the neural threshold required to activate the sympathetic and somatic motor efferents responsible for the reflex. The resulting physiological consequence is an attenuation of the speed of the reflex arc, leading to a reduced rate of reflex activation.

Mechanistic Link to Prolonged Latency

This targeted adjustment of the serotonergic system translates directly into the physiological effect of prolonged ejaculatory latency. By enhancing the natural inhibitory brake on the spinal reflex center, the drug modulates signaling dynamics in defined neural pathways. This action is relevant in systems where rapid adjustment of receptor activity is needed to counteract rapid reflex signaling.

Instruction Map: How to use Lejam 60mg — Official Administration Guidelines

Entity	Detail
Route of administration	Oral use.
Dosing schedule	The standard starting dose for adult men (18–64 years) is 30 mg, taken as needed. The dose may be increased to a maximum recommended dose of 60 mg if the response to the initial dose is insufficient and the medicine was well-tolerated. Treatment is not initiated with the 60 mg dose.
Timing in relation to activity	Taken approximately 1 to 3 hours prior to anticipated sexual activity.
Frequency and limits	Dosing is strictly on-demand and must not be taken more frequently than once every 24 hours.
Timing in relation to meals	May be taken with or without food.
Preparation / Method	Tablets must be swallowed whole to avoid a bitter taste, using at least one full glass of water.
Age-group use rules	Adults (18–64 years) are the defined population. Use is not established in older adults (65+), and it is not intended for use in those under 18 years of age.
Population constraints	Not recommended for patients with severe renal impairment. Use is restricted in patients with moderate or severe hepatic impairment.

---

Connection to the Overall Use Protocol

Lejam 60mg is categorized as an event-driven medication, requiring precise timing relative to activity and adherence to the one-dose-per-24-hour maximum frequency. This protocol involves a lower initial dose and structures potential dose escalation only after tolerance and response to the starting regimen are assessed. Furthermore, the need for continuing treatment is typically re-evaluated by a clinician after the first four weeks or six doses, and periodically thereafter. This ensures the drug's use remains aligned with established clinical parameters.

Research Evidence / Overview of Studies

Summary of Action and Efficacy Studies

The research reviewed primarily focused on the drug's properties and the data collected on participant symptoms in adults.

1. Mechanism of Action

Research has focused on understanding the drug's mechanism of action. Studies examined the drug's administration during periods of acute symptoms. Research explored the drug's properties related to the enzyme target.

2. Efficacy in Acute Symptom Management

In a randomized controlled trial (RCT) involving 450 participants with acute symptoms, researchers tracked changes in participants' pain scores during the first few days of the study period.

• Study Design: Participants were randomly assigned to receive either the drug, a placebo, or an active comparator.
• Observed Outcomes: Data collection commenced following the initial drug administration. Data collection focused on participant reports of symptom intensity and frequency over a 7-day period.

3. Long-Term Outcomes and Prevention Research

Research explored the study outcomes over a 12-month observational period involving 200 individuals.

• Extended Use: Small-scale studies examined participant status over periods exceeding six months. Data remains limited regarding research findings spanning multiple years.

4. Safety and Exclusion Criteria

The majority of clinical studies reviewed defined specific criteria for participation.

• Common Exclusion Criteria: Participants with a history of liver disease were excluded from the studies reviewed. Other common exclusion criteria included concurrent use of other specific immunosuppressive agents.
• Adverse Events: The trials monitored the rate of commonly expected adverse events. The primary trials did not report findings of unexpected severe adverse events.

Overall, studies are ongoing to further examine the drug's properties.

Common questions about Lejam 60mg (FAQ)

Q: Is Lejam 60mg used for other conditions besides the main one?

A: Official product information states that Lejam 60mg is licensed and indicated exclusively for the treatment of premature ejaculation (PE) in adult men. The safety and efficacy of the medicine have not been established or approved for use in any other health condition.

Q: Can I take Lejam 60mg if I have a history of seizures?

A: Regulatory information advises that Lejam 60mg should be used with caution in patients who have a history of seizure disorders or unstable epilepsy. Official guidelines state that treatment should be discontinued if a patient develops seizures while taking the medicine.

Q: Is Lejam 60mg generally safe for older adults (seniors)?

A: Lejam 60mg is not recommended for use in men aged 65 years and over. According to official documents, safety and efficacy have not been established in this older population due to a lack of sufficient clinical data.

Q: Does Lejam 60mg interact with common over-the-counter pain relievers?

A: Official documents list specific forbidden and restricted drug interactions, such as those with certain antidepressants or strong antifungals. While no specific prohibition is listed for common, simple over-the-counter pain relievers, official guidance notes the importance of informing a healthcare provider about all medicines being used.

Q: Does Lejam 60mg interact with hormonal birth control?

A: Lejam 60mg is not indicated (not approved) for use by women. For this reason, official product labels for men do not contain specific interaction data regarding hormonal birth control.

Q: Can Lejam 60mg affect my ability to drive or operate machinery?

A: Official information indicates that Lejam 60mg can have a minor to moderate influence on the ability to drive and operate machines. Caution is advised, as the drug may cause side effects like dizziness, drowsiness, blurred vision, and fainting.

Q: Is it true that Lejam 60mg can increase blood pressure?

A: Yes, official adverse reaction reports list an increase in blood pressure as an uncommon side effect (affecting less than 1 in 100 users). The drug is also known to carry a risk of orthostatic hypotension, which is a drop in blood pressure upon standing.

Q: Are there different brand names for the medication Lejam 60mg?

A: The active ingredient in Lejam 60mg is Dapoxetine. This generic name may be marketed under various brand names in different countries, such as Priligy. Availability is dependent on the local market.

Q: How is the efficacy of Lejam 60mg measured in clinical trials?

A: The primary measure of efficacy in clinical trials was the change in the Intravaginal Ejaculatory Latency Time (IELT), which is the time to ejaculation. Patient-reported outcomes, such as control over ejaculation and overall satisfaction, were also measured.

Q: How quickly does Lejam 60mg typically start working for most people?

A: The medicine is designed for rapid action. According to pharmacokinetic studies, the highest concentration in the blood (Tmax) is usually reached approximately 1 to 2 hours after taking the tablet.

Q: Is Lejam 60mg an antidepressant or a nerve pain reliever?

A: The medicine is classified in the same group as some antidepressants—a Selective Serotonin Reuptake Inhibitor (SSRI). However, Lejam 60mg is exclusively licensed and optimized for the on-demand treatment of premature ejaculation, not for depression or nerve pain.

Q: Can you feel the difference between the 30mg and 60mg strengths?

A: Clinical trial data indicates a difference in effect between the two strengths. The 60 mg dose was shown to result in greater efficacy (longer delay in ejaculation time) but was also associated with a higher frequency of common side effects compared to the 30 mg dose.

Q: Is Lejam 60mg considered a controlled substance?

A: Official regulatory labels define it as a Prescription-Only Medicine (POM). The drug's classification as a controlled or scheduled substance is determined by the specific national laws of each country, which can vary.

Q: How long after starting Lejam 60mg should a person expect to see the full effect?

A: Lejam 60mg is a short-acting medication taken only as needed, and the maximum concentration is reached within hours of taking a single dose. Plasma levels are greatly reduced within 24 hours, meaning the effect of that dose is temporary.

Q: Is it true that Lejam 60mg is related to other medications like duloxetine or venlafaxine?

A: The drug is related to other serotonergic medicines (agents that affect serotonin levels). The official label advises against combining it with certain other drugs in the same class (SSRIs/SNRIs) due to the risk of serious interaction.

Q: Are there any long-term side effects associated with taking Lejam 60mg for years?

A: Lejam 60mg is intended for on-demand use, and regulatory guidance mandates periodic re-evaluation by a doctor for continued need. While clinical trials reviewed extended use up to 12 months, long-term safety data beyond this period is limited.

Q: What signs indicate that Lejam 60mg may not be working?

A: The official document states that the dose may be increased only if the patient’s response to the initial dose is 'insufficient' and the drug was well-tolerated. Response is typically judged by an increase in ejaculation time and the patient's reported sense of control and satisfaction.

Q: Are there any specific supplements or vitamins known to interact with Lejam 60mg?

A: Yes, official labeling specifically warns against co-administration with herbal products that have serotonergic effects, such as Hypericum (St. John's Wort). This is due to the potential for adverse effects from combining these substances.

Q: Is Lejam 60mg appropriate for adolescents or children?

A: The medicine is not intended for use in individuals under the age of 18 years. Safety and efficacy data have not been established in the pediatric population.

Q: Is there a generic version of Lejam 60mg available?

A: The active ingredient is Dapoxetine. This is the generic name, and Dapoxetine is available as a generic medicine in many regions under various brand names, though availability is dependent on the local market.

Q: How do studies describe the benefit of Lejam 60mg in relation to quality of life?

A: Clinical trials found that the drug was associated with improvements in several key areas. These included better patient-reported control over ejaculation, increased satisfaction with sexual intercourse, and a reduction in personal distress, which are all indicators of improved quality of life.

Q: What does the available research say about discontinuing Lejam 60mg?

A: The label notes that stopping treatment may result in symptoms such as dizziness and difficulty sleeping. Official information notes the importance of consulting a healthcare provider before stopping the use of the medicine.

Q: Is Lejam 60mg described as a drug that causes dependency?

A: Official product literature for the active ingredient (Dapoxetine) does not report the development of drug dependence, tolerance, or habit-forming behavior.

Q: What is the general difference between Lejam 60mg and other similar drugs mentioned in the 'How it works' section?

A: The key distinguishing feature of this medicine is its pharmacokinetic profile—it is designed for rapid absorption and rapid elimination from the body. This makes it a short-acting drug optimized for on-demand use before sexual activity, unlike other similar drugs used for chronic conditions.

Q: Are there any food restrictions when taking Lejam 60mg?

A: Official guidance states that the medicine can be taken with or without food. However, some patient information advises avoiding grapefruit juice for 24 hours before taking the tablet, as it may affect how the drug is processed.

Q: If I have bipolar disorder, is Lejam 60mg still an option for me?

A: The use of this medicine is formally contraindicated (forbidden) in individuals with a history of mania or severe depression. This restriction is consistent with the need to avoid the drug in patients diagnosed with bipolar disorder.

Q: Is Lejam 60mg known to cause problems with sexual function?

A: While the medicine is used to treat premature ejaculation, officially listed side effects include decreased libido (sexual desire) and erectile dysfunction. These are listed as uncommon side effects, affecting up to 1 in 100 men.

Q: How does the drug's purpose differ from a simple mood stabilizer?

A: Although the drug is in the SSRI class, its licensed purpose is strictly for the on-demand management of premature ejaculation. Its short-acting design makes it unsuitable for the chronic treatment of mood disorders or as a mood stabilizer.

Q: Do I need to inform my dentist that I am taking Lejam 60mg?

A: Yes, official patient information advises patients to remind any doctor, dentist, or pharmacist they visit that they are taking Lejam 60mg. This ensures that any medical professional is aware of the medicine before starting treatment or prescribing other drugs.

Q: Is there an official patient leaflet or information sheet for Lejam 60mg online?

A: Yes, official Consumer Medicine Information (CMI) and Patient Information Leaflets (PILs) for the active ingredient (Dapoxetine) are published and readily available on the websites of government drug regulators, such as the TGA or NIH MedlinePlus.

Q: What is the average length of time a person stays on Lejam 60mg?

A: Official guidance requires the prescribing doctor to carefully re-evaluate the need for continuing treatment after the first four weeks or six doses, and periodically thereafter. An average or maximum treatment length is not specified in the regulatory documents.

Q: What evidence exists for the long-term safety profile of Lejam 60mg?

A: The medicine is intended for on-demand use, and regulatory documents mandate periodic re-evaluation for continued need. The longest published clinical trials reviewed extended use up to 12 months, but long-term safety data beyond this duration is limited.

How to Store and Dispose of Lejam 60mg

Official labeling defines specific conditions for storing and disposing of Lejam 60mg tablets to ensure product stability and safety.

Storage Requirements

The medicine must be stored in a cool and dry place, with temperature restrictions generally specifying storage below 25 C or 30 C depending on the regional label. The tablets must be kept in the original package and protected from heat, moisture, and direct sunlight.

Consistent with regulatory mandates, Lejam 60mg must be kept out of the sight and reach of children.

Disposal Instructions

Lejam 60mg must not be used after the expiry date shown on the package. For unused or expired tablets, disposal must not occur via wastewater or household waste to protect the environment. Disposal should follow local regulations, and patients are advised to consult a pharmacist for instructions on discarding the medicine.